Clinical trial
A Study to Assess the Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Osteoarthritis Patients
NCT01980940 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess the Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Osteoarthritis Patients
- Lead sponsor
- Organon and Co
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 23, 2013
- Completion date
- November 26, 2014
- Enrollment
- 70 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis pain